John Stuppin - Neurobiological Technologies Chairman
| NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
Chairman
Mr. John B. Stuppin serves as Director of Neurobiological Technologies, Inc., since July 1994. He is a founder of the Company and has served as a Director of the Company since September 1988. From September 1987 until October 1990, Mr. Stuppin served as President of the Company, from November 1990 to August 1993 as cochairman of the Board of Directors, from October 1990 until September 1991 as Executive Vice President, and from April 1991 until July 1994 as Treasurer. He also served as the acting Chief Financial Officer of the Company from the Companys inception through December 1993 and served as a parttime employee of the Company in a business development capacity from December 1990 to December 2005. Mr. Stuppin is an investment banker and a VCist. He has over 40 years experience in the start up and management of companies active in emerging technologies and was the president of a manufacturing company. He is chairman of the board of Energy Focus, Inc. Mr. Stuppin holds an A.B. degree from Columbia University. since 1994.
| Age | 90 |
| Tenure | 30 years |
| Phone | 510 595 6000 |
| Web | http://www.ntii.com |
Management Performance
Neurobiological Technologies Leadership Team
Elected by the shareholders, the Neurobiological Technologies' board of directors comprises two types of representatives: Neurobiological Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neurobiological. The board's role is to monitor Neurobiological Technologies' management team and ensure that shareholders' interests are well served. Neurobiological Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neurobiological Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Stuppin, Founder, Director, Chairman of Nominating and Corporate Governance Committee and Member of Special Committee | ||
| Stephen Ferruolo, Sec |
Neurobiological Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neurobiological Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.0 | ||||
| Profit Margin | 0.74 % | ||||
| Operating Margin | 0.77 % | ||||
| Current Valuation | (26.24 M) | ||||
| Shares Outstanding | 27.02 M | ||||
| Shares Owned By Institutions | 9.41 % | ||||
| Number Of Shares Shorted | 37.6 K | ||||
| Price To Book | 0.07 X | ||||
| Price To Sales | 0.0004 X | ||||
| Revenue | 6.03 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |